The facility is acquired for a total consideration of USD 7.7 million, it added. As part of the acquisition, the existing workforce of the facility will transition into Biocon Generics Inc. The facility has the potential for capacity expansion of up to 2 billion tablets/capsules per year.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LY6Fuat
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» Biocon acquires Eywa Pharma's US-based plant for USD 7.7 mn
https://ift.tt/tzGuLhK
No comments:
Post a Comment